(2026). A cost-effectiveness analysis comparing pembrolizumab combined with chemotherapy versus chemotherapy alone for advanced biliary tract cancer: US and China perspectives. PLOS ONE.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"A Cost-effectiveness Analysis Comparing Pembrolizumab Combined with Chemotherapy Versus Chemotherapy Alone for Advanced Biliary Tract Cancer: US and China Perspectives."
PLOS ONE 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"A Cost-effectiveness Analysis Comparing Pembrolizumab Combined with Chemotherapy Versus Chemotherapy Alone for Advanced Biliary Tract Cancer: US and China Perspectives."
PLOS ONE, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.